amifostine anhydrous has been researched along with Uterine Neoplasms in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, I | 1 |
| Mitsuhashi, N | 1 |
| Itoh, J | 1 |
| Okazaki, A | 1 |
| Ikeda, H | 1 |
| Suto, H | 1 |
| Yamakawa, M | 1 |
| Nozaki, M | 1 |
| Miyaishi, K | 1 |
| Niibe, H | 1 |
1 other study available for amifostine anhydrous and Uterine Neoplasms
| Article | Year |
|---|---|
[Clinical use of radioprotector amifostine (YM-08310)].
Topics: Adolescent; Adult; Aged; Amifostine; Child; Diarrhea; Female; Head and Neck Neoplasms; Humans; Lymph | 1984 |